Canadian pharmaceutical manufacturer of generic injectables
SteriMax manufactures generic injectable pharmaceuticals for the Canadian market, operating a legacy ERP stack (SAP, SQL Server, NetSuite, Oracle Hyperion) typical of regulated manufacturing. Active projects span product launches, regulatory submissions for complex injectables, and rebate process automation — but the hiring mix (data, finance, logistics, regulatory) and pain-point concentration (master data fragmentation, SAP control gaps, rebate calculation accuracy) suggest internal process maturity is the constraint, not market demand.
SteriMax is a privately held Canadian pharmaceutical manufacturer based in Oakville, Ontario, specializing in generic injectable products. The company serves the domestic pharmaceutical market and operates under GMP and regulatory submission requirements. Operations span product development and regulatory approval (complex injectable submissions, post-approval changes), manufacturing logistics (cost optimization, shortage prevention), and financial processes (rebate calculations and compliance). The organization runs on a traditional ERP footprint anchored in SAP, SQL Server, and NetSuite, with ongoing investments in system enhancements and data governance.
SteriMax runs SAP, SQL Server, NetSuite, Oracle Hyperion, Dynamics 365, and Microsoft Office. Active upgrades and enhancements to SAP are underway, alongside a new centralized data catalog project.
SteriMax is launching new products, automating workflows, improving supply chain processes, streamlining rebate calculations, and submitting regulatory applications for complex injectable products. Data catalog centralization and SAP control enhancements are also underway.
Other companies in the same industry, closest in size